These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6607008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system.
    Sausville EA, Worsham GF, Matthews MJ, Makuch RW, Fischmann AB, Schechter GP, Gazdar AF, Bunn PA.
    Hum Pathol; 1985 Nov; 16(11):1098-109. PubMed ID: 3876976
    [Abstract] [Full Text] [Related]

  • 4. Clinical features of cutaneous T-cell lymphoma.
    Abel EA.
    Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
    Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, Prince HM, Quaglino P.
    Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
    [Abstract] [Full Text] [Related]

  • 6. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
    Sausville EA, Eddy JL, Makuch RW, Fischmann AB, Schechter GP, Matthews M, Glatstein E, Ihde DC, Kaye F, Veach SR.
    Ann Intern Med; 1988 Sep 01; 109(5):372-82. PubMed ID: 3408055
    [Abstract] [Full Text] [Related]

  • 7. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE, Lefterova MI, Suarez CJ, Tavallaee M, Kim YH, Schrijver I, Kim J, Gratzinger D.
    Hum Pathol; 2015 Sep 01; 46(9):1382-9. PubMed ID: 26193796
    [Abstract] [Full Text] [Related]

  • 8. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
    Hoppe RT, Wood GS, Abel EA.
    Curr Probl Cancer; 1990 Sep 01; 14(6):293-371. PubMed ID: 2245651
    [Abstract] [Full Text] [Related]

  • 9. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B.
    Clin Bull; 1977 Sep 01; 7(3):91-7. PubMed ID: 308870
    [No Abstract] [Full Text] [Related]

  • 10. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination.
    Bunn PA, Huberman MS, Whang-Peng J, Schechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD.
    Ann Intern Med; 1980 Aug 01; 93(2):223-30. PubMed ID: 6967710
    [Abstract] [Full Text] [Related]

  • 11. Cutaneous T-cell lymphoma.
    Lansigan F, Choi J, Foss FM.
    Hematol Oncol Clin North Am; 2008 Oct 01; 22(5):979-96, x. PubMed ID: 18954747
    [Abstract] [Full Text] [Related]

  • 12. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
    Vonderheid EC, Diamond LW, van Vloten WA, Scheffer E, Meijer CJ, Cashell AW, Hardman JM, Lai SM, Hermans J, Matthews MJ.
    Cancer; 1994 Jan 01; 73(1):207-18. PubMed ID: 8275427
    [Abstract] [Full Text] [Related]

  • 13. A modified staging classification for cutaneous T-cell lymphoma.
    Kashani-Sabet M, McMillan A, Zackheim HS.
    J Am Acad Dermatol; 2001 Nov 01; 45(5):700-6. PubMed ID: 11606919
    [Abstract] [Full Text] [Related]

  • 14. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
    Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, Papadavid E, Evison F, Knobler R, Quaglino P, Vermeer MH.
    Eur J Cancer; 2018 Apr 01; 93():47-56. PubMed ID: 29477101
    [Abstract] [Full Text] [Related]

  • 15. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.
    Kern DE, Kidd PG, Moe R, Hanke D, Olerud JE.
    Arch Dermatol; 1998 Feb 01; 134(2):158-64. PubMed ID: 9487207
    [Abstract] [Full Text] [Related]

  • 16. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W.
    Dtsch Med Wochenschr; 1988 Feb 05; 113(5):184-9. PubMed ID: 3276493
    [No Abstract] [Full Text] [Related]

  • 17. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF, Newland K, McCormack C, Lade S, Prince HM.
    Australas J Dermatol; 2016 Aug 05; 57(3):182-91. PubMed ID: 25988337
    [Abstract] [Full Text] [Related]

  • 18. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ, Horchowski N, Tubiana N, Gabriel B, Gastaut JA, Hassoun J, Jouve I, Carcassone Y, Bonerandi JJ.
    Dermatologica; 1988 Aug 05; 177(2):82-97. PubMed ID: 3262542
    [Abstract] [Full Text] [Related]

  • 19. Using molecular biologic analysis of T-cell receptor gene rearrangements to stage cutaneous T-cell lymphoma.
    Wood GS.
    Arch Dermatol; 1998 Feb 05; 134(2):221-3. PubMed ID: 9487215
    [No Abstract] [Full Text] [Related]

  • 20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb 05; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.